Search results
Results from the WOW.Com Content Network
A subsequent increase in PSA levels by 2.0 ng/mL [disputed – discuss] above the nadir is the currently accepted definition of prostate cancer recurrence after radiation therapy. [citation needed] Recurrent prostate cancer detected by a rise in PSA levels after curative treatment is referred to as a "biochemical recurrence". The likelihood of ...
The highest levels of acid phosphatase are found in metastasized prostate cancer. Diseases of the bone, such as Paget's disease or hyperparathyroidism, diseases of blood cells, such as sickle-cell disease or multiple myeloma or lysosomal storage diseases, such as Gaucher's disease, will show moderately increased levels.
In some prostate cancers, PSMA is the second-most upregulated gene product, with an 8- to 12-fold increase over levels in noncancerous prostate cells. [19] Because of this high expression, PSMA is being developed as potential biomarker for therapy and imaging of some cancers. [ 20 ]
Supplementing with zinc long-term has also been associated with poor cholesterol levels. When zinc toxicity does happen, it has been shown to come "almost exclusively" from supplements over food ...
PSA levels between 4 and 10 suggest you could have about a 25 percent chance of prostate cancer, and levels over 10 signal that your chance of having the cancer is more than 50 percent.
While zinc is required for a healthy immune system to perform at an optimal level, there is a point when its requirement is met and more zinc will not increase immune system response.” Zinc ...
The molecular communication between androgen receptor (AR) and FHL2 is linked to the disease development of prostate cancer such as aggressiveness and biochemical recurrence (i.e., rise in circulatory prostate-specific antigen (PSA) levels after surgical or radiography treatment) [46] [47] FHL2 expression is profoundly initiated by androgen ...
Men with high PSA levels are often recommended to repeat the blood test four to six weeks later, as PSA levels can fluctuate unrelated to prostate cancer. [17] Benign prostatic hyperplasia, prostate infection, recent ejaculation, and some urological procedures can increase PSA levels; taking 5α-reductase inhibitors can decrease PSA levels. [15]